APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Opioid Analgesics

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Opioid Analgesics Market Analysis and Forecast 2026-2032

Report ID 174019260230 December 2025193 pages

Choose your research edition.

Industry ResearchOpioid Analgesics Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Opioid Analgesics Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Opioid Analgesics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Opioid Analgesics Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Opioid Analgesics Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Opioid Analgesics market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Opioid Analgesics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Opioid Analgesics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Opioid Analgesics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Opioid Analgesics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Opioid Analgesics include Assertio Holdings, Inc, Bausch Health, Boehringer Ingelheim International GmbH, Endo International Plc, F. Hoffmann-La Roche AG, Purdue Pharmaceuticals L.P., Sanofi S.A., Teva Pharmaceuticals and Abbott Laboratories, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Opioid Analgesics, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Opioid Analgesics, also provides the sales of main regions and countries. Of the upcoming market potential for Opioid Analgesics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Opioid Analgesics sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Opioid Analgesics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Opioid Analgesics sales, projected growth trends, production technology, application and end-user industry.

Opioid Analgesics Segment by Company

Assertio Holdings, Inc

Bausch Health

Boehringer Ingelheim International GmbH

Endo International Plc

F. Hoffmann-La Roche AG

Purdue Pharmaceuticals L.P.

Sanofi S.A.

Teva Pharmaceuticals

Abbott Laboratories

Bayer AG

GlaxoSmithKline plc

Pfizer Inc.

Novartis AG

Johnson & Johnson

Opioid Analgesics Segment by Type

Morphine

Methadone

OxyContin

Vicodin

Others

Opioid Analgesics Segment by Application

Surgical Pain

Neuropathic Pain

Cancer Pain

Others

Opioid Analgesics Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Opioid Analgesics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Opioid Analgesics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Opioid Analgesics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Opioid Analgesics in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Opioid Analgesics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Opioid Analgesics sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Opioid Analgesics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Morphine Major Manufacturers Table 3. Methadone Major Manufacturers Table 4. OxyContin Major Manufacturers Table 5. Vicodin Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global Opioid Analgesics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Surgical Pain Major Manufacturers Table 9. Neuropathic Pain Major Manufacturers Table 10. Cancer Pain Major Manufacturers Table 11. Others Major Manufacturers Table 12. Opioid Analgesics Industry Trends Table 13. Opioid Analgesics Industry Drivers Table 14. Opioid Analgesics Industry Opportunities and Challenges Table 15. Opioid Analgesics Industry Restraints Table 16. Global Opioid Analgesics Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Opioid Analgesics Revenue by Region (2021-2026) & (US$ Million) Table 18. Global Opioid Analgesics Revenue by Region (2027-2032) & (US$ Million) Table 19. Global Opioid Analgesics Revenue Market Share by Region (2021-2026) Table 20. Global Opioid Analgesics Revenue Market Share by Region (2027-2032) Table 21. Global Opioid Analgesics Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Tons) Table 22. Global Opioid Analgesics Sales by Region (2021-2026) & (Tons) Table 23. Global Opioid Analgesics Sales by Region (2027-2032) & (Tons) Table 24. Global Opioid Analgesics Sales Market Share by Region (2021-2026) Table 25. Global Opioid Analgesics Sales Market Share by Region (2027-2032) Table 26. Global Opioid Analgesics Revenue by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Opioid Analgesics Revenue Market Share by Manufacturers (2021-2026) Table 28. Global Opioid Analgesics Sales by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Opioid Analgesics Sales Market Share by Manufacturers (2021-2026) Table 30. Global Opioid Analgesics Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 31. Global Opioid Analgesics Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 32. Global Opioid Analgesics Key Manufacturers Manufacturing Sites & Headquarters Table 33. Global Opioid Analgesics Manufacturers, Product Type & Application Table 34. Global Opioid Analgesics Manufacturers' Establishment Date Table 35. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 36. Global Opioid Analgesics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 37. Global Opioid Analgesics Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Opioid Analgesics Revenue by Type (2021-2026) & (US$ Million) Table 39. Global Opioid Analgesics Revenue by Type (2027-2032) & (US$ Million) Table 40. Global Opioid Analgesics Revenue Market Share by Type (2021-2026) Table 41. Global Opioid Analgesics Revenue Market Share by Type (2027-2032) Table 42. Global Opioid Analgesics Sales by Type 2021 VS 2025 VS 2032 (Tons) Table 43. Global Opioid Analgesics Sales by Type (2021-2026) & (Tons) Table 44. Global Opioid Analgesics Sales by Type (2027-2032) & (Tons) Table 45. Global Opioid Analgesics Sales Market Share by Type (2021-2026) Table 46. Global Opioid Analgesics Sales Market Share by Type (2027-2032) Table 47. Global Opioid Analgesics Price by Type (2021-2026) & (US$/Ton) Table 48. Global Opioid Analgesics Price by Type (2027-2032) & (US$/Ton) Table 49. Global Opioid Analgesics Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Opioid Analgesics Revenue by Application (2021-2026) & (US$ Million) Table 51. Global Opioid Analgesics Revenue by Application (2027-2032) & (US$ Million) Table 52. Global Opioid Analgesics Revenue Market Share by Application (2021-2026) Table 53. Global Opioid Analgesics Revenue Market Share by Application (2027-2032) Table 54. Global Opioid Analgesics Sales by Application 2021 VS 2025 VS 2032 (Tons) Table 55. Global Opioid Analgesics Sales by Application (2021-2026) & (Tons) Table 56. Global Opioid Analgesics Sales by Application (2027-2032) & (Tons) Table 57. Global Opioid Analgesics Sales Market Share by Application (2021-2026) Table 58. Global Opioid Analgesics Sales Market Share by Application (2027-2032) Table 59. Global Opioid Analgesics Price by Application (2021-2026) & (US$/Ton) Table 60. Global Opioid Analgesics Price by Application (2027-2032) & (US$/Ton) Table 61. Assertio Holdings, Inc Company Information Table 62. Assertio Holdings, Inc Business Overview Table 63. Assertio Holdings, Inc Opioid Analgesics Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 64. Assertio Holdings, Inc Opioid Analgesics Product Portfolio Table 65. Assertio Holdings, Inc Recent Development Table 66. Bausch Health Company Information Table 67. Bausch Health Business Overview Table 68. Bausch Health Opioid Analgesics Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 69. Bausch Health Opioid Analgesics Product Portfolio Table 70. Bausch Health Recent Development Table 71. Boehringer Ingelheim International GmbH Company Information Table 72. Boehringer Ingelheim International GmbH Business Overview Table 73. Boehringer Ingelheim International GmbH Opioid Analgesics Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 74. Boehringer Ingelheim International GmbH Opioid Analgesics Product Portfolio Table 75. Boehringer Ingelheim International GmbH Recent Development Table 76. Endo International Plc Company Information Table 77. Endo International Plc Business Overview Table 78. Endo International Plc Opioid Analgesics Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 79. Endo International Plc Opioid Analgesics Product Portfolio Table 80. Endo International Plc Recent Development Table 81. F. Hoffmann-La Roche AG Company Information Table 82. F. Hoffmann-La Roche AG Business Overview Table 83. F. Hoffmann-La Roche AG Opioid Analgesics Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 84. F. Hoffmann-La Roche AG Opioid Analgesics Product Portfolio Table 85. F. Hoffmann-La Roche AG Recent Development Table 86. Purdue Pharmaceuticals L.P. Company Information Table 87. Purdue Pharmaceuticals L.P. Business Overview Table 88. Purdue Pharmaceuticals L.P. Opioid Analgesics Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 89. Purdue Pharmaceuticals L.P. Opioid Analgesics Product Portfolio Table 90. Purdue Pharmaceuticals L.P. Recent Development Table 91. Sanofi S.A. Company Information Table 92. Sanofi S.A. Business Overview Table 93. Sanofi S.A. Opioid Analgesics Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 94. Sanofi S.A. Opioid Analgesics Product Portfolio Table 95. Sanofi S.A. Recent Development Table 96. Teva Pharmaceuticals Company Information Table 97. Teva Pharmaceuticals Business Overview Table 98. Teva Pharmaceuticals Opioid Analgesics Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 99. Teva Pharmaceuticals Opioid Analgesics Product Portfolio Table 100. Teva Pharmaceuticals Recent Development Table 101. Abbott Laboratories Company Information Table 102. Abbott Laboratories Business Overview Table 103. Abbott Laboratories Opioid Analgesics Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 104. Abbott Laboratories Opioid Analgesics Product Portfolio Table 105. Abbott Laboratories Recent Development Table 106. Bayer AG Company Information Table 107. Bayer AG Business Overview Table 108. Bayer AG Opioid Analgesics Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 109. Bayer AG Opioid Analgesics Product Portfolio Table 110. Bayer AG Recent Development Table 111. GlaxoSmithKline plc Company Information Table 112. GlaxoSmithKline plc Business Overview Table 113. GlaxoSmithKline plc Opioid Analgesics Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 114. GlaxoSmithKline plc Opioid Analgesics Product Portfolio Table 115. GlaxoSmithKline plc Recent Development Table 116. Pfizer Inc. Company Information Table 117. Pfizer Inc. Business Overview Table 118. Pfizer Inc. Opioid Analgesics Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 119. Pfizer Inc. Opioid Analgesics Product Portfolio Table 120. Pfizer Inc. Recent Development Table 121. Novartis AG Company Information Table 122. Novartis AG Business Overview Table 123. Novartis AG Opioid Analgesics Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 124. Novartis AG Opioid Analgesics Product Portfolio Table 125. Novartis AG Recent Development Table 126. Johnson & Johnson Company Information Table 127. Johnson & Johnson Business Overview Table 128. Johnson & Johnson Opioid Analgesics Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 129. Johnson & Johnson Opioid Analgesics Product Portfolio Table 130. Johnson & Johnson Recent Development Table 131. North America Opioid Analgesics Revenue by Type (2021-2026) & (US$ Million) Table 132. North America Opioid Analgesics Revenue by Type (2027-2032) & (US$ Million) Table 133. North America Opioid Analgesics Sales by Type (2021-2026) & (Tons) Table 134. North America Opioid Analgesics Sales by Type (2027-2032) & (Tons) Table 135. North America Opioid Analgesics Sales Price by Type (2021-2026) & (US$/Ton) Table 136. North America Opioid Analgesics Sales Price by Type (2027-2032) & (US$/Ton) Table 137. North America Opioid Analgesics Revenue by Application (2021-2026) & (US$ Million) Table 138. North America Opioid Analgesics Revenue by Application (2027-2032) & (US$ Million) Table 139. North America Opioid Analgesics Sales by Application (2021-2026) & (Tons) Table 140. North America Opioid Analgesics Sales by Application (2027-2032) & (Tons) Table 141. North America Opioid Analgesics Sales Price by Application (2021-2026) & (US$/Ton) Table 142. North America Opioid Analgesics Sales Price by Application (2027-2032) & (US$/Ton) Table 143. North America Opioid Analgesics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 144. North America Opioid Analgesics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 145. North America Opioid Analgesics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 146. North America Opioid Analgesics Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 147. North America Opioid Analgesics Sales by Country (2021-2026) & (Tons) Table 148. North America Opioid Analgesics Sales by Country (2027-2032) & (Tons) Table 149. North America Opioid Analgesics Sales Price by Country (2021-2026) & (US$/Ton) Table 150. North America Opioid Analgesics Sales Price by Country (2027-2032) & (US$/Ton) Table 151. United States Opioid Analgesics Revenue (2021-2032) & (US$ Million) Table 152. Canada Opioid Analgesics Revenue (2021-2032) & (US$ Million) Table 153. Europe Opioid Analgesics Revenue by Type (2021-2026) & (US$ Million) Table 154. Europe Opioid Analgesics Revenue by Type (2027-2032) & (US$ Million) Table 155. Europe Opioid Analgesics Sales by Type (2021-2026) & (Tons) Table 156. Europe Opioid Analgesics Sales by Type (2027-2032) & (Tons) Table 157. Europe Opioid Analgesics Sales Price by Type (2021-2026) & (US$/Ton) Table 158. Europe Opioid Analgesics Sales Price by Type (2027-2032) & (US$/Ton) Table 159. Europe Opioid Analgesics Revenue by Application (2021-2026) & (US$ Million) Table 160. Europe Opioid Analgesics Revenue by Application (2027-2032) & (US$ Million) Table 161. Europe Opioid Analgesics Sales by Application (2021-2026) & (Tons) Table 162. Europe Opioid Analgesics Sales by Application (2027-2032) & (Tons) Table 163. Europe Opioid Analgesics Sales Price by Application (2021-2026) & (US$/Ton) Table 164. Europe Opioid Analgesics Sales Price by Application (2027-2032) & (US$/Ton) Table 165. Europe Opioid Analgesics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 166. Europe Opioid Analgesics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 167. Europe Opioid Analgesics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 168. Europe Opioid Analgesics Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 169. Europe Opioid Analgesics Sales by Country (2021-2026) & (Tons) Table 170. Europe Opioid Analgesics Sales by Country (2027-2032) & (Tons) Table 171. Europe Opioid Analgesics Sales Price by Country (2021-2026) & (US$/Ton) Table 172. Europe Opioid Analgesics Sales Price by Country (2027-2032) & (US$/Ton) Table 173. Germany Opioid Analgesics Revenue (2021-2032) & (US$ Million) Table 174. France Opioid Analgesics Revenue (2021-2032) & (US$ Million) Table 175. U.K. Opioid Analgesics Revenue (2021-2032) & (US$ Million) Table 176. Italy Opioid Analgesics Revenue (2021-2032) & (US$ Million) Table 177. Netherlands Opioid Analgesics Revenue (2021-2032) & (US$ Million) Table 178. China Opioid Analgesics Revenue by Type (2021-2026) & (US$ Million) Table 179. China Opioid Analgesics Revenue by Type (2027-2032) & (US$ Million) Table 180. China Opioid Analgesics Sales by Type (2021-2026) & (Tons) Table 181. China Opioid Analgesics Sales by Type (2027-2032) & (Tons) Table 182. China Opioid Analgesics Sales Price by Type (2021-2026) & (US$/Ton) Table 183. China Opioid Analgesics Sales Price by Type (2027-2032) & (US$/Ton) Table 184. China Opioid Analgesics Revenue by Application (2021-2026) & (US$ Million) Table 185. China Opioid Analgesics Revenue by Application (2027-2032) & (US$ Million) Table 186. China Opioid Analgesics Sales by Application (2021-2026) & (Tons) Table 187. China Opioid Analgesics Sales by Application (2027-2032) & (Tons) Table 188. China Opioid Analgesics Sales Price by Application (2021-2026) & (US$/Ton) Table 189. China Opioid Analgesics Sales Price by Application (2027-2032) & (US$/Ton) Table 190. Asia Opioid Analgesics Revenue by Type (2021-2026) & (US$ Million) Table 191. Asia Opioid Analgesics Revenue by Type (2027-2032) & (US$ Million) Table 192. Asia Opioid Analgesics Sales by Type (2021-2026) & (Tons) Table 193. Asia Opioid Analgesics Sales by Type (2027-2032) & (Tons) Table 194. Asia Opioid Analgesics Sales Price by Type (2021-2026) & (US$/Ton) Table 195. Asia Opioid Analgesics Sales Price by Type (2027-2032) & (US$/Ton) Table 196. Asia Opioid Analgesics Revenue by Application (2021-2026) & (US$ Million) Table 197. Asia Opioid Analgesics Revenue by Application (2027-2032) & (US$ Million) Table 198. Asia Opioid Analgesics Sales by Application (2021-2026) & (Tons) Table 199. Asia Opioid Analgesics Sales by Application (2027-2032) & (Tons) Table 200. Asia Opioid Analgesics Sales Price by Application (2021-2026) & (US$/Ton) Table 201. Asia Opioid Analgesics Sales Price by Application (2027-2032) & (US$/Ton) Table 202. Asia Opioid Analgesics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 203. Asia Opioid Analgesics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 204. Asia Opioid Analgesics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 205. Asia Opioid Analgesics Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 206. Asia Opioid Analgesics Sales by Country (2021-2026) & (Tons) Table 207. Asia Opioid Analgesics Sales by Country (2027-2032) & (Tons) Table 208. Asia Opioid Analgesics Sales Price by Country (2021-2026) & (US$/Ton) Table 209. Asia Opioid Analgesics Sales Price by Country (2027-2032) & (US$/Ton) Table 210. Japan Opioid Analgesics Revenue (2021-2032) & (US$ Million) Table 211. South Korea Opioid Analgesics Revenue (2021-2032) & (US$ Million) Table 212. India Opioid Analgesics Revenue (2021-2032) & (US$ Million) Table 213. Australia Opioid Analgesics Revenue (2021-2032) & (US$ Million) Table 214. China Taiwan Opioid Analgesics Revenue (2021-2032) & (US$ Million) Table 215. Southeast Asia Opioid Analgesics Revenue (2021-2032) & (US$ Million) Table 216. SAMEA Opioid Analgesics Revenue by Type (2021-2026) & (US$ Million) Table 217. SAMEA Opioid Analgesics Revenue by Type (2027-2032) & (US$ Million) Table 218. SAMEA Opioid Analgesics Sales by Type (2021-2026) & (Tons) Table 219. SAMEA Opioid Analgesics Sales by Type (2027-2032) & (Tons) Table 220. SAMEA Opioid Analgesics Sales Price by Type (2021-2026) & (US$/Ton) Table 221. SAMEA Opioid Analgesics Sales Price by Type (2027-2032) & (US$/Ton) Table 222. SAMEA Opioid Analgesics Revenue by Application (2021-2026) & (US$ Million) Table 223. SAMEA Opioid Analgesics Revenue by Application (2027-2032) & (US$ Million) Table 224. SAMEA Opioid Analgesics Sales by Application (2021-2026) & (Tons) Table 225. SAMEA Opioid Analgesics Sales by Application (2027-2032) & (Tons) Table 226. SAMEA Opioid Analgesics Sales Price by Application (2021-2026) & (US$/Ton) Table 227. SAMEA Opioid Analgesics Sales Price by Application (2027-2032) & (US$/Ton) Table 228. SAMEA Opioid Analgesics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 229. SAMEA Opioid Analgesics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 230. SAMEA Opioid Analgesics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 231. SAMEA Opioid Analgesics Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 232. SAMEA Opioid Analgesics Sales by Country (2021-2026) & (Tons) Table 233. SAMEA Opioid Analgesics Sales by Country (2027-2032) & (Tons) Table 234. SAMEA Opioid Analgesics Sales Price by Country (2021-2026) & (US$/Ton) Table 235. SAMEA Opioid Analgesics Sales Price by Country (2027-2032) & (US$/Ton) Table 236. Brazil Opioid Analgesics Revenue (2021-2032) & (US$ Million) Table 237. Argentina Opioid Analgesics Revenue (2021-2032) & (US$ Million) Table 238. Chile Opioid Analgesics Revenue (2021-2032) & (US$ Million) Table 239. Colombia Opioid Analgesics Revenue (2021-2032) & (US$ Million) Table 240. Peru Opioid Analgesics Revenue (2021-2032) & (US$ Million) Table 241. Saudi Arabia Opioid Analgesics Revenue (2021-2032) & (US$ Million) Table 242. Israel Opioid Analgesics Revenue (2021-2032) & (US$ Million) Table 243. UAE Opioid Analgesics Revenue (2021-2032) & (US$ Million) Table 244. Turkey Opioid Analgesics Revenue (2021-2032) & (US$ Million) Table 245. Iran Opioid Analgesics Revenue (2021-2032) & (US$ Million) Table 246. Egypt Opioid Analgesics Revenue (2021-2032) & (US$ Million) Table 247. Key Raw Materials Table 248. Raw Materials Key Suppliers Table 249. Opioid Analgesics Distributors List Table 250. Opioid Analgesics Customers List Table 251. Research Programs/Design for This Report Table 252. Authors List of This Report Table 253. Secondary Sources Table 254. Primary Sources List of Figures Figure 1. Opioid Analgesics Image Figure 2. Global Opioid Analgesics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Opioid Analgesics Market Size Share 2021 VS 2025 VS 2032 Figure 4. Morphine Image Figure 5. Methadone Image Figure 6. OxyContin Image Figure 7. Vicodin Image Figure 8. Others Image Figure 9. Global Opioid Analgesics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Opioid Analgesics Market Size Share 2021 VS 2025 VS 2032 Figure 11. Surgical Pain Image Figure 12. Neuropathic Pain Image Figure 13. Cancer Pain Image Figure 14. Others Image Figure 15. Global Opioid Analgesics Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Opioid Analgesics Revenue (2021-2032) & (US$ Million) Figure 17. Global Opioid Analgesics Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Opioid Analgesics Revenue Market Share by Region: 2025 Versus 2032 Figure 19. Global Opioid Analgesics Revenue Market Share by Region (2021-2032) Figure 20. Global Opioid Analgesics Sales (2021-2032) & (Tons) Figure 21. Global Opioid Analgesics Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 22. Global Opioid Analgesics Sales Market Share by Region (2021-2032) Figure 23. US & Canada & Mexico Opioid Analgesics Sales YoY (2021-2032) & (Tons) Figure 24. Europe Opioid Analgesics Sales YoY (2021-2032) & (Tons) Figure 25. China Opioid Analgesics Sales YoY (2021-2032) & (Tons) Figure 26. Asia (Excluding China) Opioid Analgesics Sales YoY (2021-2032) & (Tons) Figure 27. South America, Middle East and Africa Opioid Analgesics Sales YoY (2021-2032) & (Tons) Figure 28. Global Opioid Analgesics Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 29. Global Opioid Analgesics Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 30. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Global Opioid Analgesics Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 32. Global Opioid Analgesics Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Opioid Analgesics Revenue Market Share by Type (2021-2032) Figure 34. Global Opioid Analgesics Sales by Type (2021 VS 2025 VS 2032) & (Tons) Figure 35. Global Opioid Analgesics Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 36. Global Opioid Analgesics Sales Market Share by Type (2021-2032) Figure 37. Global Opioid Analgesics Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 38. Global Opioid Analgesics Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Opioid Analgesics Revenue Market Share by Application (2021-2032) Figure 40. Global Opioid Analgesics Sales by Application (2021 VS 2025 VS 2032) & (Tons) Figure 41. Global Opioid Analgesics Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 42. Global Opioid Analgesics Sales Market Share by Application (2021-2032) Figure 43. North America Opioid Analgesics Revenue Share by Type (2021-2032) Figure 44. North America Opioid Analgesics Sales Share by Type (2021-2032) Figure 45. North America Opioid Analgesics Revenue Share by Application (2021-2032) Figure 46. North America Opioid Analgesics Sales Share by Application (2021-2032) Figure 47. North America Opioid Analgesics Revenue Share by Country (2021-2032) Figure 48. North America Opioid Analgesics Sales Share by Country (2021-2032) Figure 49. Europe Opioid Analgesics Revenue Share by Type (2021-2032) Figure 50. Europe Opioid Analgesics Sales Share by Type (2021-2032) Figure 51. Europe Opioid Analgesics Revenue Share by Application (2021-2032) Figure 52. Europe Opioid Analgesics Sales Share by Application (2021-2032) Figure 53. Europe Opioid Analgesics Revenue Share by Country (2021-2032) Figure 54. Europe Opioid Analgesics Sales Share by Country (2021-2032) Figure 55. China Opioid Analgesics Revenue Share by Type (2021-2032) Figure 56. China Opioid Analgesics Sales Share by Type (2021-2032) Figure 57. China Opioid Analgesics Revenue Share by Application (2021-2032) Figure 58. China Opioid Analgesics Sales Share by Application (2021-2032) Figure 59. Asia Opioid Analgesics Revenue Share by Type (2021-2032) Figure 60. Asia Opioid Analgesics Sales Share by Type (2021-2032) Figure 61. Asia Opioid Analgesics Revenue Share by Application (2021-2032) Figure 62. Asia Opioid Analgesics Sales Share by Application (2021-2032) Figure 63. Asia Opioid Analgesics Revenue Share by Country (2021-2032) Figure 64. Asia Opioid Analgesics Sales Share by Country (2021-2032) Figure 65. SAMEA Opioid Analgesics Revenue Share by Type (2021-2032) Figure 66. SAMEA Opioid Analgesics Sales Share by Type (2021-2032) Figure 67. SAMEA Opioid Analgesics Revenue Share by Application (2021-2032) Figure 68. SAMEA Opioid Analgesics Sales Share by Application (2021-2032) Figure 69. SAMEA Opioid Analgesics Revenue Share by Country (2021-2032) Figure 70. SAMEA Opioid Analgesics Sales Share by Country (2021-2032) Figure 71. Opioid Analgesics Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Opioid Analgesics Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • Morphine
  • Methadone
  • OxyContin
  • Vicodin
  • Others
Applications
  • Surgical Pain
  • Neuropathic Pain
  • Cancer Pain
  • Others
Companies covered
  • Assertio Holdings, Inc
  • Bausch Health
  • Boehringer Ingelheim International GmbH
  • Endo International Plc
  • F. Hoffmann-La Roche AG
  • Purdue Pharmaceuticals L.P.
  • Sanofi S.A.
  • Teva Pharmaceuticals
  • Abbott Laboratories
  • Bayer AG
  • GlaxoSmithKline plc
  • Pfizer Inc.
  • Novartis AG
  • Johnson & Johnson

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Opioid Analgesics Market by Type
  3. 1.2.1 Global Opioid Analgesics Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Morphine
  5. 1.2.3 Methadone
  6. 1.2.4 OxyContin
  7. 1.2.5 Vicodin
  8. 1.2.6 Others
  9. 1.3 Opioid Analgesics Market by Application
  10. 1.3.1 Global Opioid Analgesics Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Surgical Pain
  12. 1.3.3 Neuropathic Pain
  13. 1.3.4 Cancer Pain
  14. 1.3.5 Others
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Opioid Analgesics Market Dynamics
  1. 2.1 Opioid Analgesics Industry Trends
  2. 2.2 Opioid Analgesics Industry Drivers
  3. 2.3 Opioid Analgesics Industry Opportunities and Challenges
  4. 2.4 Opioid Analgesics Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Opioid Analgesics Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Opioid Analgesics Revenue by Region
  3. 3.2.1 Global Opioid Analgesics Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Opioid Analgesics Revenue by Region (2021-2026)
  5. 3.2.3 Global Opioid Analgesics Revenue by Region (2027-2032)
  6. 3.2.4 Global Opioid Analgesics Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Opioid Analgesics Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Opioid Analgesics Sales by Region
  9. 3.4.1 Global Opioid Analgesics Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Opioid Analgesics Sales by Region (2021-2026)
  11. 3.4.3 Global Opioid Analgesics Sales by Region (2027-2032)
  12. 3.4.4 Global Opioid Analgesics Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Opioid Analgesics Revenue by Manufacturers
  2. 4.1.1 Global Opioid Analgesics Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Opioid Analgesics Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Opioid Analgesics Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Opioid Analgesics Sales by Manufacturers
  6. 4.2.1 Global Opioid Analgesics Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Opioid Analgesics Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Opioid Analgesics Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Opioid Analgesics Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Opioid Analgesics Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Opioid Analgesics Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Opioid Analgesics Manufacturers, Product Type & Application
  13. 4.7 Global Opioid Analgesics Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Opioid Analgesics Market CR5 and HHI
  16. 4.8.2 2025 Opioid Analgesics Tier 1, Tier 2, and Tier 3
5 Opioid Analgesics Market by Type
  1. 5.1 Global Opioid Analgesics Revenue by Type
  2. 5.1.1 Global Opioid Analgesics Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Opioid Analgesics Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Opioid Analgesics Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Opioid Analgesics Sales by Type
  6. 5.2.1 Global Opioid Analgesics Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Opioid Analgesics Sales by Type (2021-2032) & (Tons)
  8. 5.2.3 Global Opioid Analgesics Sales Market Share by Type (2021-2032)
  9. 5.3 Global Opioid Analgesics Price by Type
6 Opioid Analgesics Market by Application
  1. 6.1 Global Opioid Analgesics Revenue by Application
  2. 6.1.1 Global Opioid Analgesics Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Opioid Analgesics Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Opioid Analgesics Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Opioid Analgesics Sales by Application
  6. 6.2.1 Global Opioid Analgesics Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Opioid Analgesics Sales by Application (2021-2032) & (Tons)
  8. 6.2.3 Global Opioid Analgesics Sales Market Share by Application (2021-2032)
  9. 6.3 Global Opioid Analgesics Price by Application
7 Company Profiles
  1. 7.1 Assertio Holdings, Inc
  2. 7.1.1 Assertio Holdings, Inc Company Information
  3. 7.1.2 Assertio Holdings, Inc Business Overview
  4. 7.1.3 Assertio Holdings, Inc Opioid Analgesics Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Assertio Holdings, Inc Opioid Analgesics Product Portfolio
  6. 7.1.5 Assertio Holdings, Inc Recent Developments
  7. 7.2 Bausch Health
  8. 7.2.1 Bausch Health Company Information
  9. 7.2.2 Bausch Health Business Overview
  10. 7.2.3 Bausch Health Opioid Analgesics Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Bausch Health Opioid Analgesics Product Portfolio
  12. 7.2.5 Bausch Health Recent Developments
  13. 7.3 Boehringer Ingelheim International GmbH
  14. 7.3.1 Boehringer Ingelheim International GmbH Company Information
  15. 7.3.2 Boehringer Ingelheim International GmbH Business Overview
  16. 7.3.3 Boehringer Ingelheim International GmbH Opioid Analgesics Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Boehringer Ingelheim International GmbH Opioid Analgesics Product Portfolio
  18. 7.3.5 Boehringer Ingelheim International GmbH Recent Developments
  19. 7.4 Endo International Plc
  20. 7.4.1 Endo International Plc Company Information
  21. 7.4.2 Endo International Plc Business Overview
  22. 7.4.3 Endo International Plc Opioid Analgesics Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Endo International Plc Opioid Analgesics Product Portfolio
  24. 7.4.5 Endo International Plc Recent Developments
  25. 7.5 F. Hoffmann-La Roche AG
  26. 7.5.1 F. Hoffmann-La Roche AG Company Information
  27. 7.5.2 F. Hoffmann-La Roche AG Business Overview
  28. 7.5.3 F. Hoffmann-La Roche AG Opioid Analgesics Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 F. Hoffmann-La Roche AG Opioid Analgesics Product Portfolio
  30. 7.5.5 F. Hoffmann-La Roche AG Recent Developments
  31. 7.6 Purdue Pharmaceuticals L.P.
  32. 7.6.1 Purdue Pharmaceuticals L.P. Company Information
  33. 7.6.2 Purdue Pharmaceuticals L.P. Business Overview
  34. 7.6.3 Purdue Pharmaceuticals L.P. Opioid Analgesics Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Purdue Pharmaceuticals L.P. Opioid Analgesics Product Portfolio
  36. 7.6.5 Purdue Pharmaceuticals L.P. Recent Developments
  37. 7.7 Sanofi S.A.
  38. 7.7.1 Sanofi S.A. Company Information
  39. 7.7.2 Sanofi S.A. Business Overview
  40. 7.7.3 Sanofi S.A. Opioid Analgesics Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Sanofi S.A. Opioid Analgesics Product Portfolio
  42. 7.7.5 Sanofi S.A. Recent Developments
  43. 7.8 Teva Pharmaceuticals
  44. 7.8.1 Teva Pharmaceuticals Company Information
  45. 7.8.2 Teva Pharmaceuticals Business Overview
  46. 7.8.3 Teva Pharmaceuticals Opioid Analgesics Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Teva Pharmaceuticals Opioid Analgesics Product Portfolio
  48. 7.8.5 Teva Pharmaceuticals Recent Developments
  49. 7.9 Abbott Laboratories
  50. 7.9.1 Abbott Laboratories Company Information
  51. 7.9.2 Abbott Laboratories Business Overview
  52. 7.9.3 Abbott Laboratories Opioid Analgesics Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Abbott Laboratories Opioid Analgesics Product Portfolio
  54. 7.9.5 Abbott Laboratories Recent Developments
  55. 7.10 Bayer AG
  56. 7.10.1 Bayer AG Company Information
  57. 7.10.2 Bayer AG Business Overview
  58. 7.10.3 Bayer AG Opioid Analgesics Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Bayer AG Opioid Analgesics Product Portfolio
  60. 7.10.5 Bayer AG Recent Developments
  61. 7.11 GlaxoSmithKline plc
  62. 7.11.1 GlaxoSmithKline plc Company Information
  63. 7.11.2 GlaxoSmithKline plc Business Overview
  64. 7.11.3 GlaxoSmithKline plc Opioid Analgesics Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 GlaxoSmithKline plc Opioid Analgesics Product Portfolio
  66. 7.11.5 GlaxoSmithKline plc Recent Developments
  67. 7.12 Pfizer Inc.
  68. 7.12.1 Pfizer Inc. Company Information
  69. 7.12.2 Pfizer Inc. Business Overview
  70. 7.12.3 Pfizer Inc. Opioid Analgesics Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Pfizer Inc. Opioid Analgesics Product Portfolio
  72. 7.12.5 Pfizer Inc. Recent Developments
  73. 7.13 Novartis AG
  74. 7.13.1 Novartis AG Company Information
  75. 7.13.2 Novartis AG Business Overview
  76. 7.13.3 Novartis AG Opioid Analgesics Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Novartis AG Opioid Analgesics Product Portfolio
  78. 7.13.5 Novartis AG Recent Developments
  79. 7.14 Johnson & Johnson
  80. 7.14.1 Johnson & Johnson Company Information
  81. 7.14.2 Johnson & Johnson Business Overview
  82. 7.14.3 Johnson & Johnson Opioid Analgesics Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Johnson & Johnson Opioid Analgesics Product Portfolio
  84. 7.14.5 Johnson & Johnson Recent Developments
8 North America
  1. 8.1 North America Opioid Analgesics Market Size by Type
  2. 8.1.1 North America Opioid Analgesics Revenue by Type (2021-2032)
  3. 8.1.2 North America Opioid Analgesics Sales by Type (2021-2032)
  4. 8.1.3 North America Opioid Analgesics Price by Type (2021-2032)
  5. 8.2 North America Opioid Analgesics Market Size by Application
  6. 8.2.1 North America Opioid Analgesics Revenue by Application (2021-2032)
  7. 8.2.2 North America Opioid Analgesics Sales by Application (2021-2032)
  8. 8.2.3 North America Opioid Analgesics Price by Application (2021-2032)
  9. 8.3 North America Opioid Analgesics Market Size by Country
  10. 8.3.1 North America Opioid Analgesics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Opioid Analgesics Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Opioid Analgesics Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Opioid Analgesics Market Size by Type
  2. 9.1.1 Europe Opioid Analgesics Revenue by Type (2021-2032)
  3. 9.1.2 Europe Opioid Analgesics Sales by Type (2021-2032)
  4. 9.1.3 Europe Opioid Analgesics Price by Type (2021-2032)
  5. 9.2 Europe Opioid Analgesics Market Size by Application
  6. 9.2.1 Europe Opioid Analgesics Revenue by Application (2021-2032)
  7. 9.2.2 Europe Opioid Analgesics Sales by Application (2021-2032)
  8. 9.2.3 Europe Opioid Analgesics Price by Application (2021-2032)
  9. 9.3 Europe Opioid Analgesics Market Size by Country
  10. 9.3.1 Europe Opioid Analgesics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Opioid Analgesics Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Opioid Analgesics Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Opioid Analgesics Market Size by Type
  2. 10.1.1 China Opioid Analgesics Revenue by Type (2021-2032)
  3. 10.1.2 China Opioid Analgesics Sales by Type (2021-2032)
  4. 10.1.3 China Opioid Analgesics Price by Type (2021-2032)
  5. 10.2 China Opioid Analgesics Market Size by Application
  6. 10.2.1 China Opioid Analgesics Revenue by Application (2021-2032)
  7. 10.2.2 China Opioid Analgesics Sales by Application (2021-2032)
  8. 10.2.3 China Opioid Analgesics Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Opioid Analgesics Market Size by Type
  2. 11.1.1 Asia Opioid Analgesics Revenue by Type (2021-2032)
  3. 11.1.2 Asia Opioid Analgesics Sales by Type (2021-2032)
  4. 11.1.3 Asia Opioid Analgesics Price by Type (2021-2032)
  5. 11.2 Asia Opioid Analgesics Market Size by Application
  6. 11.2.1 Asia Opioid Analgesics Revenue by Application (2021-2032)
  7. 11.2.2 Asia Opioid Analgesics Sales by Application (2021-2032)
  8. 11.2.3 Asia Opioid Analgesics Price by Application (2021-2032)
  9. 11.3 Asia Opioid Analgesics Market Size by Country
  10. 11.3.1 Asia Opioid Analgesics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Opioid Analgesics Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Opioid Analgesics Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Opioid Analgesics Market Size by Type
  2. 12.1.1 SAMEA Opioid Analgesics Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Opioid Analgesics Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Opioid Analgesics Price by Type (2021-2032)
  5. 12.2 SAMEA Opioid Analgesics Market Size by Application
  6. 12.2.1 SAMEA Opioid Analgesics Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Opioid Analgesics Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Opioid Analgesics Price by Application (2021-2032)
  9. 12.3 SAMEA Opioid Analgesics Market Size by Country
  10. 12.3.1 SAMEA Opioid Analgesics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Opioid Analgesics Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Opioid Analgesics Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Opioid Analgesics Value Chain Analysis
  2. 13.1.1 Opioid Analgesics Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Opioid Analgesics Production Mode & Process
  6. 13.2 Opioid Analgesics Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Opioid Analgesics Distributors
  9. 13.2.3 Opioid Analgesics Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst